JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap5.46B
EV5.46B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
446.6
426.5
581.1
431.2
247.8
307.3
272.6
258.6
295.1
319.5
Revenue % Chg.
-20.9%
-4.5%
36.2%
-25.8%
-42.5%
24.0%
-11.3%
-5.1%
14.1%
14.7%
Cost of Revenue
377.0
374.8
513.7
338.0
160.0
216.3
188.8
184.0
210.7
234.5
Gross Profit
69.6
51.7
67.3
93.3
87.9
91.0
83.8
74.6
84.4
85.1
Gross Profit Margin
15.6%
12.1%
11.6%
21.6%
35.5%
29.6%
30.7%
28.8%
28.6%
26.6%
R&D Expenses
0.8
1.0
2.3
5.9
7.4
2.0
5.5
3.1
4.2
4.3
Selling, General, & Admin Expenses
28.0
26.3
31.1
50.8
70.3
76.0
73.3
64.8
71.0
71.4
Other Expenses
16.5
17.3
23.4
17.5
15.5
13.5
9.4
9.8
11.5
11.7
Operating Income
24.4
7.1
10.5
19.1
-5.3
21.0
-4.8
0.1
-0.1
-1.7
Operating Income Margin
5.5%
1.7%
1.8%
4.4%
-2.1%
6.8%
-1.8%
0.0%
-0.0%
-0.5%
Total Other Income/Expenses Net
-5.0
5.4
-3.5
7.7
-27.2
-9.7
-68.6
5.6
-10.9
-6.5
Income Before Tax
19.4
12.4
7.0
26.7
-32.5
11.3
-73.4
5.7
-11.0
-8.2
Income Before Tax Margin
4.3%
2.9%
1.2%
6.2%
-13.1%
3.7%
-26.9%
2.2%
-3.7%
-2.6%
Income Tax Expense
6.7
3.3
-4.4
7.0
8.6
2.3
0.5
2.7
0.4
0.2
Net Income
5.9
7.2
10.5
19.4
-41.6
9.4
-73.9
3.3
-11.4
-8.3
Net Income Margin
1.3%
1.7%
1.8%
4.5%
-16.8%
3.1%
-27.1%
1.3%
-3.9%
-2.6%
Weighted Avg. Shares Out
628.5
637.8
685.7
719.5
721.1
717.0
713.3
757.2
692.7
730.0
EPS
0.0
0.0
0.0
0.0
-0.1
0.0
-0.1
0.0
-0.0
-0.0
EPS % Chg.
-19.8%
18.5%
36.4%
76.2%
—
—
—
—
—
—
Weighted Avg. Shares Out Dil
628.5
637.8
685.7
719.5
721.1
717.0
713.3
757.2
692.7
730.0
EPS Diluted
0.0
0.0
0.0
0.0
-0.1
0.0
-0.1
0.0
-0.0
-0.0
Interest Income
0.9
0.8
1.0
1.1
1.2
0.7
0.7
0.3
0.7
0.5
Interest Expense
11.3
9.1
6.4
6.1
5.7
7.6
9.4
9.4
10.9
11.0
EBIT
9.0
4.2
1.6
21.7
-37.0
4.3
-82.1
-3.4
-21.2
-18.6
EBIT Margin
2.0%
1.0%
0.3%
5.0%
-14.9%
1.4%
-30.1%
-1.3%
-7.2%
-5.8%
Depreciation & Amortization
6.8
8.4
10.2
12.3
13.0
12.6
12.2
7.2
6.9
4.7
EBITDA
15.8
12.6
11.8
34.0
-23.9
16.9
-69.9
3.8
-14.2
-13.9
EBITDA Margin
3.5%
3.0%
2.0%
7.9%
-9.7%
5.5%
-25.7%
1.5%
-4.8%
-4.4%